/PRNewswire/ Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted Radiotherapy (TRT) to benefit cancer patients in China, today.
University of Minnesota Twin Cities researchers have developed a technology that allows amputees to move a robotic arm using brain signals instead of their muscles.
Scientists from the University of Minnesota Twin Cities have engineered a more precise, less invasive technology that enables amputees to control a robotic arm using signals from their brain rather than their muscles.